Delta Accumulation, LLC Eli Lilly & CO Put Options Transaction History

Delta Accumulation, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $6.23 Million - $7.82 Million	-8,600 Reduced 22.57%	29,500 $26.7 Million
Q1 2024 May 10, 2024	BUY	$592.2 - $792.28 $12.7 Million - $17 Million	21,400 Added 128.14%	38,100 $29.6 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $472,671 - $557,217	-900 Reduced 5.11%	16,700 $9.73 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $7.65 Million - $10.5 Million	17,600 New	17,600 $9.45 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $5.96 Million - $7 Million	-21,400 Reduced 80.15%	5,300 $1.72 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $5 Million - $6.21 Million	21,300 Added 394.44%	26,700 $7.65 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.21 Million - $1.51 Million	5,400 New	5,400 $1.49 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Delta Accumulation, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Accumulation, LLC with notifications on news.